Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pharmaceutical composition for treating hypertension

A composition and technology for hypertension, applied in the field of medicine, can solve problems such as increasing coronary flow, and achieve the effects of reducing incidence, good synergistic antihypertensive effect, and good compliance

Inactive Publication Date: 2014-01-29
SHIHUIDA PHARMA GRP (JILIN) LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the national anti-aging drug seminar held by the Chinese Pharmaceutical Association in the 1980s, academic exchanges were carried out on the research of Apocynum leaf. Clinical trial studies and documentation certificates of the Society, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Northwest Institute of Botany, Chinese Academy of Sciences, Institute of Materia Medica, Chinese Academy of Medical Sciences, and other units and pharmaceutical-related units in Shaanxi, Beijing, Shanghai, Nanjing, etc. Apocynum leaves contain a large amount of flavonoids, triterpenes, organic acids, amino acids and other chemical components. Further research on the chemical structure of flavonoids is quercetin and isoquercetin glycosides. Its pharmacological effects include lowering blood pressure, lowering blood fat, and increasing coronary artery flow. It has good curative effect on high blood pressure and high blood fat, especially on dizziness symptoms and improving sleep quality. At the same time, it can enhance immunity, prevent colds, relieve asthma and relieve cough, eliminate depression, promote blood circulation and beautify skin, relieve alcohol and protect liver, and degrade smoke Toxins, softening blood vessels, defecation and diuresis, etc., but have side effects of bradycardia in the heart

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating hypertension
  • Pharmaceutical composition for treating hypertension

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Weigh 3 mg of levamlodipine besylate (calculated as levamlodipine) and 3000 mg of apocynum leaf extract, and mix them uniformly to prepare pharmaceutical composition 1.

Embodiment 2

[0031] Weigh 90 mg of levamlodipine besylate (calculated as levamlodipine) and 300 mg of Apocynum apocynum extract, and mix them uniformly to prepare pharmaceutical composition 2.

Embodiment 3

[0033] Weigh 7.5 mg of levamlodipine besylate (calculated as levamlodipine) and 2400 mg of Apocynum apocynum extract, and mix them uniformly to prepare pharmaceutical composition 3.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition. The pharmaceutical composition comprises Levoamlodipine or a pharmaceutically-acceptable salt and dogbane leaf extracts. The pharmaceutical composition has a good therapeutic effect on hypertension and has less adverse effects.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a composition composed of levamlodipine or a pharmaceutically acceptable salt thereof and apocynum leaf extract, and the application of the composition in the preparation of drugs for treating hypertension. technical background [0002] Hypertension is a common chronic disease of the cardiovascular system. At present, there is no effective cure in the world. Once the disease occurs, it needs to be taken for life, which seriously endangers human health. In 2009, Professor Liu Lisheng, chairman of the World Hypertension Federation, pointed out: "19% of adults in my country suffer from hypertension, and the number of patients reaches 220 million. At the same time, there are still 10 million new patients every year." Hypertension can cause damage to the heart, brain, kidney and other organs, and is closely related to sugar and lipid metabolism disorders and diabetes, which can significantly r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/24A61P9/12A61K31/4422
Inventor 李环杨彦玲薛传校张喜田陈明
Owner SHIHUIDA PHARMA GRP (JILIN) LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products